Latest News for: listing rules

Edit

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The Daily Record - Dunn 21 Mar 2026
Evolus, Inc. (NASDAQ. EOLS) a performance beauty company with a focus on building an aesthetic portfolio of consumer ....
Edit

Stagwell Inc. (STGW) Reports Equity Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The Daily Record - Dunn 21 Mar 2026
NEW YORK CITY, NY / ACCESS Newswire / March 20, 2026 / Stagwell Inc. (the "Company") announced today the grant of ....
Edit

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Caledonian Record 21 Mar 2026
(NASDAQ.
Edit

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Caledonian Record 21 Mar 2026
(NASDAQ.
Edit

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Caledonian Record 21 Mar 2026
(Nasdaq.
Edit

Failure to Satisfy Listing Rule (Form 8-K) (GoHealth Inc)

Public Technologies 20 Mar 2026
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ... In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has been provided a compliance ...
Edit

Failure to Satisfy Listing Rule (Form 8-K) (Faraday Future Intelligent Electric Inc)

Public Technologies 20 Mar 2026
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ... by Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement").
Edit

Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

Nasdaq Globe Newswire 20 Mar 2026
The equity award was approved by the Compensation Committee of the Board of Directors in accordance with Nasdaq Rule 5635(c)(4) and made as ...
Edit

Failure to Satisfy Listing Rule (Form 8-K) (Alzamend Neuro Inc)

Public Technologies 20 Mar 2026
) Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ... In accordance with Nasdaq Listing Rules, the Company has been provided an initial period ...
Edit

Failure to Satisfy Listing Rule (Form 8-K) (Quince Therapeutics Inc)

Public Technologies 20 Mar 2026
ITEM 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ... to resolve the deficiency and regain compliance with Nasdaq Listing Rule 5450(a)(1).
Edit

Stagwell Inc. (STGW) Reports Equity Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Stagwell Inc)

Public Technologies 20 Mar 2026
). NEW YORK CITY, NY / ACCESS Newswire / March 20, 2026 / Stagwell Inc ... The Company granted these awards as a material inducement to employment in accordance with Nasdaq Listing Rule 5635(c)(4) ... About Stagwell ... Join us at https.//www.stagwellglobal.com.
Edit

Failure to Satisfy Listing Rule (Form 8-K) (Lifeward Ltd)

Public Technologies 20 Mar 2026
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ... consistent with the cure period set out in Nasdaq Listing Rule 5605(c)(4) of the Nasdaq rules.
Edit

Failure to Satisfy Listing Rule (Form 8-K) (MaxCyte Inc)

Public Technologies 20 Mar 2026
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ... for continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1).
Edit

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Ultragenyx Pharmaceutical Inc)

Public Technologies 20 Mar 2026
... Inducement Plan, with a grant date of March 16, 2026, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
Edit

Failure to Satisfy Listing Rule (Form 8-K) (NextNRG Inc)

Public Technologies 20 Mar 2026
The Nasdaq Listing Rules require listed securities to maintain a minimum bid price of $1.00 per share and, based upon the closing bid price for the last 30 consecutive business days, the Company no longer meets this requirement.

Article Search

tools
×
×
×
×